2 of the best ASX 200 shares according to analysts

CSL Limited (ASX: CSL) and this ASX 200 share could be among the best options for Australian investors to choose from right now…

| More on:
A smiling woman with a handful of $100 notes, indicating strong dividend payments

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market is home to a good number of high quality companies with strong business models.

Among the best of them are arguably the shares listed below. Here's why these ASX shares could be quality options for investors right now:

CSL Limited (ASX: CSL)

The first ASX share to consider is CSL. While this leading biotechnology company would be a top option at most times, now appears to be a particularly good time to make an investment. This is due to a recent and sharp pullback in the CSL share price.

This weakness has been driven by plasma collection headwinds caused by the pandemic. The good news is that increased demand for flu vaccines from the Seqirus business looks set to offset much or even all of this. And with plasma collections expected to improve once the pandemic passes, CSL appears well-placed for growth once conditions ease.

This should be supported by its lucrative R&D pipeline, which is filled with a number of potentially lucrative therapies that could be launched in the not so distant future. One of those is Clazakizumab. It is a humanised recombinant monoclonal antibody targeting interleukin-6 for the potential treatment of chronic active antibody-mediated rejection. This is the leading cause of long-term rejection in kidney transplant recipients. If successful, peak sales are estimated to be US$5.4 billion per annum.

Citi currently has a buy rating and $310 price target on its shares.

Xero Limited (ASX: XRO)

Another option to consider is Xero. This cloud-based business and accounting platform provider has been growing strongly over the last few years.

This has been driven by the shift to the cloud, its international expansion, acquisitions, increasing revenue per user, and its evolution into a full service solution.

The good news is that these same trends look set to underpin further strong growth over the next decade. This should be supported by its burgeoning app ecosystem, which Goldman Sachs is incredibly positive on.

According to a note, the broker estimates that Xero has a core total addressable market (TAM) of NZ$14 billion across its key markets. However, if it can successfully broaden and monetise its app ecosystem and expand into new geographies, Goldman believe it would open a further NZ$62 billion in TAM. As a result, it believes Xero has "a multi-decade runway for strong revenue growth."

Goldman Sachs has a buy rating and $153.00 price target on its shares.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A piggy bank on the cloud in the blue sky symbolising a record high share price.
52-Week Highs

12 ASX 200 shares that smashed historical peak prices today

Twelve ASX 200 shares rose to new multi-year peaks in an otherwise quiet day of trading.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors saw another day of mild gains for the stock market this Thursday.

Read more »

Two boats on the water with crates with the words trade war in the middle.
Share Market News

Trump's tariffs blocked by trade court: Which ASX 200 stocks could benefit the most?

These 3 ASX 200 stocks have heavy tariffs exposure.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Broker Notes

How this undervalued ASX All Ords share could rocket 80% in a year

A leading fund manager expects a big turnaround for this beaten-down ASX All Ords stock.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today

These shares are having a good session today. But why are investors buying them?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why ALS, Black Cat, Boss Energy, and Soul Patts shares are falling today

These shares are falling on Thursday. Let's find out why.

Read more »

A car dealer stands amid a selection of cars parked in a showroom.
Broker Notes

Up 77% in a year, guess how much more upside Macquarie tips for Eagers Automotive shares

Macquarie released its latest analysis on Eagers Automotive fast rising shares this morning.

Read more »

Boy looks quizzical standing in front of a graph.
Share Market News

Big ASX 200 news! Stock market whipsaws as Trump's tariffs struck down

Markets initially surged on news that Trump's tariffs are out.

Read more »